A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP

Clinical trial NCT04850118 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04850118
Sponsor: Beacon Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

X-Linked Retinitis Pigmentosa

Start date: 2024-03-14
Primary completion: 2026-06-30
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.